Second annual Harvard FUSION symposium explores the Science and Business of Combating Antibiotic Resistance

Accelerator-supported research suggests engineered sacs called ARMMs may be uniquely suited to send therapeutics directly to affected areas of the body

Disrupting an omega-3 fatty acid transporter could open blood-brain barrier for drug delivery

Startup Magenta Therapeutics licenses technologies from Harvard, MGH, and Boston Children’s that could transform treatment